BioDue Overview
- Year Founded
-
1986
- Status
-
Private
- Employees
-
175
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
8
BioDue General Information
Description
Manufacturer of medical devices, dermo-cosmetic products, and food supplements intended to manage a large part of the production chain. The company operates versatile production facilities capable of producing multiple pharmaceutical forms, offering services including research and development (R&D), formulation, and white-label manufacturing, enabling clients to access scalable health and wellness products.
Contact Information
Website
www.biodue.comCorporate Office
- Via Ambrogio Lorenzetti 3/a
- Sambuca, Barberino Tavarnelle
- 50028 Florence
- Italy
Corporate Office
- Via Ambrogio Lorenzetti 3/a
- Sambuca, Barberino Tavarnelle
- 50028 Florence
- Italy
BioDue Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BioDue Patents
BioDue Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3142942-A1 | An improved capsule for substances to be mixed at the time of use | Active | 16-May-2014 | ||
| EP-3142942-B1 | An improved capsule for substances to be mixed at the time of use | Active | 16-May-2014 | ||
| US-20170057712-A1 | An improved capsule for substances to be mixed at the time of use | Active | 16-May-2014 | ||
| WO-2015173661-A1 | An improved capsule for substances to be mixed at the time of use | Inactive | 16-May-2014 | ||
| US-9834351-B2 | Capsule for substances to be mixed at the time of use | Active | 16-May-2014 | B65D51/2842 |
BioDue Signals
BioDue Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BioDue Investments (8)
BioDue’s most recent deal was a Corporate with Rolf Kullgren. The deal was made on 30-Sep-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Rolf Kullgren | 30-Sep-2025 | Corporate | Other Commercial Products | ||
| Biokosmes | 11-May-2025 | Buyout/LBO | BPO/Outsource Services | ||
| BMG Pharma (Healthea Licensing) | 26-Feb-2025 | Buyout/LBO | Therapeutic Devices | ||
| Pharcomed | 29-Apr-2021 | Buyout/LBO | Medical Supplies | ||
| Farcoderma | 03-Aug-2020 | Buyout/LBO | Pharmaceuticals |
BioDue Exits (1)
BioDue’s most recent exit was on 12-Jun-2017 from Two Bee. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Two Bee | 12-Jun-2017 | Completed |
|
BioDue Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Farcoderma | Torre Pallavicina, Italy | 2006 | |
| Biokosmes | Bosisio Parini, Italy | 1983 |
BioDue FAQs
-
When was BioDue founded?
BioDue was founded in 1986.
-
Where is BioDue headquartered?
BioDue is headquartered in Florence, Italy.
-
What is the size of BioDue?
BioDue has 175 total employees.
-
What industry is BioDue in?
BioDue’s primary industry is Personal Products.
-
Is BioDue a private or public company?
BioDue is a Private company.
-
What is BioDue’s current revenue?
The current revenue for BioDue is .
-
How much funding has BioDue raised over time?
BioDue has raised $4.45M.
-
Who are BioDue’s investors?
The Riverside Company has invested in BioDue.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process